NCT06956755Recruiting
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
Source: ClinicalTrials.gov · Last updated 11 Sept 2026
Brief summary (registry, in English)
The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS and therapy-related acute myeloid leukemia
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 6990 (estimated)
- First submitted
- 5 Mar 2025
- Start date
- 7 Jul 2003
- Primary completion date
- 5 Jan 2030
- Lead sponsor
- Groupe Francophone des Myelodysplasies
- NCT number
- NCT06956755
What you commit to
- Study type: Observational
- Planned participants: 6990
- From 7 Jul 2003 to the primary completion date, 5 Jan 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \<18 years
Other
- Patient is unwilling or unable to give consent
Who the study is looking for
- Male or female
- Age \> 18 years
- Patients with myelodysplastic syndrome and therapy-related acute myeloid leukemia
- Able and willing to provide written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aspasia Stamatoullas Coordinator of this site? Confirm its status | Rouen | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.